Photo from Paolo Tarantino/Twitter
Jul 19, 2023, 18:34
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn – Paolo Tarantino
In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn. What makes a tumor resistant to T-DXd? How to treat such tumor? This open access ESMO Open article by Gabriele Antonarelli reviews the management of HER2+ MBC beyond T-DXd.
For article: Click here
Source: Paolo Tarantino/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 11:08
Jan 15, 2025, 08:14
Jan 15, 2025, 07:53
Jan 15, 2025, 07:27
Jan 15, 2025, 07:22